Midregion Prohormone Adrenomedullin and Prognosis in Patients Presenting With Acute Dyspnea: Results From the BACH (Biomarkers in Acute Heart Failure) Trial

The aim of this study was to determine the prognostic utility of midregion proadrenomedullin (MR-proADM) in all patients, cardiac and noncardiac, presenting with acute shortness of breath. The recently published BACH (Biomarkers in Acute Heart Failure) study demonstrated that MR-proADM had superior...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2011-08, Vol.58 (10), p.1057-1067
Hauptverfasser:	MAISEL, Alan, MUELLER, Christian, FILIPPATOS, Gerasimos S, DI SOMMA, Salvatore, ANAND, Inder, NG, Leong L, DANIELS, Lori B, NEATH, Sean-Xavier, CHRISTENSON, Robert, POTOCKI, Mihael, MCCORD, James, HARTMANN, Oliver, NOWAK, Richard M, MORGENTHALER, Nils G, ANKER, Stefam D, FRANK PEACOCK, W, PONIKOWSKI, Piotr, MOCKEL, Martin, HOGAN, Christopher, WU, Alan H. B, RICHARDS, Mark, CLOPTON, Paul
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenomedullin - blood Aged Aged, 80 and over Biological and medical sciences Biomarkers Biomarkers - blood Cardiology Cardiology. Vascular system Confidence intervals Dyspnea - blood Dyspnea - diagnosis Dyspnea - mortality Heart Heart attacks Heart failure Heart Failure - mortality Heart failure, cardiogenic pulmonary edema, cardiac enlargement Humans Medical prognosis Medical sciences Middle Aged Mortality Multivariate Analysis Peptides Pneumology Predictive Value of Tests Prognosis Prospective Studies Protein Precursors - blood Respiratory system : syndromes and miscellaneous diseases Variables
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!